Both companies will work to revolutionize cell culture media in biotech and the vaccine industry with animal-free, high-yield ...

Precision Medicine Group, a provider of next-generation drug development, CRO and commercialization services, has appointed Eric Hodgins as its Chief Information and Technology Officer, overseeing all ...

Bristol Myers Squibb’s Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with ...

Parexel, a clinical research organization (CRO), has appointed Charlotte Moser, MD, PhD, MBA as Chief Medical Officer.